R.A. Youness

2.5k total citations
108 papers, 1.8k citations indexed

About

R.A. Youness is a scholar working on Cancer Research, Molecular Biology and Immunology. According to data from OpenAlex, R.A. Youness has authored 108 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Cancer Research, 51 papers in Molecular Biology and 31 papers in Immunology. Recurrent topics in R.A. Youness's work include Cancer-related molecular mechanisms research (44 papers), MicroRNA in disease regulation (35 papers) and Circular RNAs in diseases (21 papers). R.A. Youness is often cited by papers focused on Cancer-related molecular mechanisms research (44 papers), MicroRNA in disease regulation (35 papers) and Circular RNAs in diseases (21 papers). R.A. Youness collaborates with scholars based in Egypt, Saudi Arabia and United Kingdom. R.A. Youness's co-authors include Mohamed Z. Gad, R.A. Assal, Amira Abdel Motaal, Ahmed Ihab Abdelaziz, Mohamed A. Farag, Sherif Ashraf Fahmy, Alyaa Dawoud, Maria Braoudaki, Nermeen A. Elkasabgy and Rabab Kamel and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Hepatology and Annals of Oncology.

In The Last Decade

R.A. Youness

103 papers receiving 1.8k citations

Peers

R.A. Youness

IMMUN

ONCOL

BIOCH

Hsiu‐Ni Kung Taiwan

Junyan Tao China

Qianqian Guo China

Francesca Tosetti Italy

Alena Hyršlová Vaculová Czechia

João Azevedo‐Silva Portugal

Elif Damla Arısan Türkiye

Seema Kumari India

Xiaoman Li China

Hsiu‐Ni Kung Taiwan

R.A. Youness

705 ×0.6

409 ×0.4

126 ×0.4

IMMUN

183 ×0.8

ONCOL

73 ×0.4

BIOCH

Citations per year, relative to R.A. Youness R.A. Youness (= 1×) peers Hsiu‐Ni Kung

Countries citing papers authored by R.A. Youness

Since Specialization

Citations

This map shows the geographic impact of R.A. Youness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.A. Youness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.A. Youness more than expected).

Fields of papers citing papers by R.A. Youness

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.A. Youness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.A. Youness. The network helps show where R.A. Youness may publish in the future.

Co-authorship network of co-authors of R.A. Youness

This figure shows the co-authorship network connecting the top 25 collaborators of R.A. Youness. A scholar is included among the top collaborators of R.A. Youness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.A. Youness. R.A. Youness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Abdelnaser, Anwar, et al.. (2025). 44P Potential combination of anti-CD-47 and natural compounds to harness calreticulin/CD47 immune checkpoint in triple-negative breast cancer patients. ESMO Open. 10. 104203–104203. 1 indexed citations

Youssef, Y. A., Sherif Ashraf Fahmy, Rabab Kamel, et al.. (2025). Extracellular vesicles: from intracellular trafficking molecules to fully fortified delivery vehicles for cancer therapeutics. Nanoscale Advances. 7(4). 934–962. 5 indexed citations

Youness, R.A., et al.. (2025). Macrophage migration inhibitory factor (MIF) and the tumor ecosystem: a tale of inflammation, immune escape, and tumor growth. Frontiers in Immunology. 16. 1636839–1636839.

Dawoud, Alyaa, R.A. Youness, Carole Bourquin, et al.. (2024). Pan-inhibition of the three H2S synthesizing enzymes restrains tumor progression and immunosuppression in breast cancer. Cancer Cell International. 24(1). 136–136. 12 indexed citations

Assal, R.A., R.A. Youness, Karim Adel Hosny, et al.. (2024). OncomiR-181a promotes carcinogenesis by repressing the extracellular matrix proteoglycan decorin in hepatocellular carcinoma. BMC Gastroenterology. 24(1). 337–337. 2 indexed citations

Youness, R.A., et al.. (2024). Role of Hydrogen Sulfide in Oncological and Non-Oncological Disorders and Its Regulation by Non-Coding RNAs: A Comprehensive Review. Non-Coding RNA. 10(1). 7–7. 12 indexed citations

Dawoud, Alyaa, et al.. (2024). Involvement of CircRNAs in regulating The “New Generation of Cancer Hallmarks”: A Special Depiction on Hepatocellular Carcinoma. Critical Reviews in Oncology/Hematology. 196. 104312–104312. 9 indexed citations

Awaji, Aeshah A., et al.. (2024). Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies. Pathology - Research and Practice. 256. 155223–155223. 8 indexed citations

Fahmy, Sherif Ashraf, et al.. (2024). Hijacking 5-Fluorouracil Chemoresistance in Triple Negative Breast Cancer via microRNAs-Loaded Chitosan Nanoparticles. International Journal of Molecular Sciences. 25(4). 2070–2070. 9 indexed citations

10.

Youness, R.A., Hekmat M. El Magdoub, Mohamed Ali, et al.. (2024). A Comprehensive Insight and In Silico Analysis of CircRNAs in Hepatocellular Carcinoma: A Step toward ncRNA-Based Precision Medicine. Cells. 13(15). 1245–1245. 23 indexed citations

11.

Elemam, Noha Mousaad, et al.. (2024). Pharmacogenomic and epigenomic approaches to untangle the enigma of IL-10 blockade in oncology. Expert Reviews in Molecular Medicine. 26. e1–e1. 9 indexed citations

12.

Hassan, Hatem A. F. M., et al.. (2024). Revolutionizing cancer therapy: nanoformulation of miRNA-34 – enhancing delivery and efficacy for various cancer immunotherapies: a review. Nanoscale Advances. 6(21). 5220–5257. 10 indexed citations

13.

Sedky, Nada K., Maria Braoudaki, Iten M. Fawzy, et al.. (2023). Box–Behnken design of thermo-responsive nano-liposomes loaded with a platinum(iv) anticancer complex: evaluation of cytotoxicity and apoptotic pathways in triple negative breast cancer cells. Nanoscale Advances. 5(19). 5399–5413. 29 indexed citations

14.

Dawoud, Alyaa, et al.. (2023). 2280P MiR-193a-3p: A pan-repressor of H2S synthesizing enzymes regulates tumorigenesis and immunosurveillance in breast cancer. Annals of Oncology. 34. S1169–S1169. 2 indexed citations

15.

Karousi, Paraskevi, et al.. (2023). Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy. International Journal of Molecular Sciences. 24(22). 16484–16484. 61 indexed citations

16.

Youness, R.A., et al.. (2023). A Snapshot of Photoresponsive Liposomes in Cancer Chemotherapy and Immunotherapy: Opportunities and Challenges. ACS Omega. 8(47). 44424–44436. 19 indexed citations

17.

Youness, R.A., et al.. (2023). Oral Delivery of Psoralidin by Mucoadhesive Surface-Modified Bilosomes Showed Boosted Apoptotic and Necrotic Effects against Breast and Lung Cancer Cells. Polymers. 15(6). 1464–1464. 40 indexed citations

18.

Youness, R.A., et al.. (2022). Fat-soluble vitamins: updated review of their role and orchestration in human nutrition throughout life cycle with sex differences. Nutrition & Metabolism. 19(1). 50 indexed citations

19.

Youness, R.A., Ahmed Z. Gad, Khaled Sanber, et al.. (2020). Targeting hydrogen sulphide signaling in breast cancer. Journal of Advanced Research. 27. 177–190. 75 indexed citations

20.

Youness, R.A., et al.. (2017). Dual targeting of cystathionine β-synthase (CBS) and cystathionine γ-lyase (CSE) by miR-4317 displays a synergistic efficacy in repressing breast cancer progression. Annals of Oncology. 28. v584–v584. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact